Dahua is committed to ensuring the quality, safety and effectiveness of our products. To enable us to provide up-to-date safety information on Sino-implant (II)/Levoplant, your support is essential, whether you are a patient, healthcare professional or facility manager.

To report an adverse event to us, please download the pharmacovigilance form and return it completed to:

沪公网安备 31023002000140号